Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Neelmini Emmanuel"'
Publikováno v:
Audiologyneuro-otology. 23(1)
Objective: Imaging characteristics and hearing outcomes in children with cochleovestibular or cochleovestibular nerve (CVN) abnormalities. Study Design: Retrospective, critical review. Setting: Tertiary referral academic center. Patients: Twenty-seve
Autor:
Eric A. White, Deborah M. Forrester, Milan Stevanovic, Dakshesh B. Patel, Neelmini Emmanuel, George R. Matcuk, Christopher J. Gottsegen
Publikováno v:
RadioGraphics. 34:1968-1986
Infections of the hand are common, particularly in immunocompromised patients, and can lead to significant morbidity, including amputation, if not treated properly. Hand infection can spread far and wide from the original site of inoculation through
Autor:
Alex W. Rogers, Charles A. Owens, Neelmini Emmanuel, M. Grace Knuttinen, Furquaan Isa, Ron C. Gaba, James T. Bui
Publikováno v:
Seminars in Interventional Radiology. 27:374-383
Reperfusion therapy using thrombolytic agents has been shown to be a safe and effective treatment strategy for arterial ischemia, venous thrombosis, massive pulmonary embolism, and acute stroke. Thrombolytic agents have evolved over the course of a f
Publikováno v:
Ultrasound quarterly. 32(3)
Carotid ultrasonography (US) is most commonly performed to identify potential areas of flow-limiting stenosis in the internal carotid artery. Identification of stenosis and unstable plaque is important because these entities are leading predictors of
Publikováno v:
Human Genetics. 119:479-495
The t(9;22) BCR/ABL fusion is associated with over 90% of chronic myelogenous and 25% of acute lymphocytic leukemia. Chromosome 11q23 translocations in acute myeloid and lymphoid leukemia cells demonstrate myeloid lymphoid leukemia (MLL) fusions with
Autor:
Yasuhiko Kaneko, Pamela L. Strissel, Janet D. Rowley, Yasuhide Hayashi, Yanming Zhang, Nancy J. Zeleznik-Le, Jianjun Chen, Brigitte Schlegelberger, Tomohiko Taki, Nimanthi Jayathilaka, Loretta S. Li, Reiner Strick, Mary Beth Neilly, Neelmini Emmanuel
Publikováno v:
Genes, Chromosomes and Cancer. 41:257-265
The recurring chromosome translocation t(11;16)(q23;p13) is detected in leukemia patients, virtually all of whom have received previous chemotherapy with topoisomerase (topo) II inhibitors. In the t(11;16), 3' CBP, on 16p13, is fused to 5' MLL, on 11
Autor:
Ginny Kamboj, Daniel L. Van Dyke, Anne E. Wiktor, Muhammad Shurafa, Neelmini Emmanuel, Janet D. Rowley, Jianjun Chen, Yanming Zhang
Publikováno v:
Genes, Chromosomes and Cancer. 40:365-370
The AML1 gene (also known as RUNX1) at 21q22 codes for core binding factor (CBF) α, which forms a heterodimer with CBF β that acts as a transcriptional activating factor. CBF is a critical regulator in the generation and differentiation of definiti
Autor:
Farhood, Saremi, Neelmini, Emmanuel, Phil F, Wu, Philip F, Wu, Lauren, Ihde, David, Shavelle, John L, Go, Damián, Sánchez-Quintana
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 34(6)
Paradoxical embolism (PDE) is an uncommon cause of acute arterial occlusion that may have catastrophic sequelae. The possibility of its presence should be considered in all patients with an arterial embolus in the absence of a cardiac or proximal art
Autor:
Ron C. Gaba, Charles A. Owens, M. Grace Knuttinen, Tami C. Carrillo, James T. Bui, Neelmini Emmanuel
Publikováno v:
Cardiovascular and interventional radiology. 34
We describe our experience with the use of the "double-wire restraining" technique to assist in the removal of two retrievable inferior vena cava filters: one had been misplaced in the right brachiocephalic vein with apex perforation of the vessel wa
Autor:
Nimanthi Jayathilaka, Heidi Gerr, Reiner Strick, Yanming Zhang, Nicole Dastugue, Michele L. Nassin, Bertil Johansson, Janet D. Rowley, Claudia Schoch, Pamela L. Strissel, Brigitte Schlegelberger, Susanne Schnittger, Neelmini Emmanuel
Publikováno v:
Blood. 104:1974-1974
The t(8;21)(q22;q22) that results in an AML1-ETO fusion gene is frequently detected in de novo and in therapy-related acute myeloid leukemia (AML) patients. Most t-AML patients with t(8;21) have received treatment with topoisomerase (topo) II inhibit